JP2023538332A - 薬液注入量計算機の非活性化の時間を決定する方法、装置、及びコンピュータプログラム製品 - Google Patents
薬液注入量計算機の非活性化の時間を決定する方法、装置、及びコンピュータプログラム製品 Download PDFInfo
- Publication number
- JP2023538332A JP2023538332A JP2023510404A JP2023510404A JP2023538332A JP 2023538332 A JP2023538332 A JP 2023538332A JP 2023510404 A JP2023510404 A JP 2023510404A JP 2023510404 A JP2023510404 A JP 2023510404A JP 2023538332 A JP2023538332 A JP 2023538332A
- Authority
- JP
- Japan
- Prior art keywords
- time
- injection
- drug
- deactivation
- controller
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 196
- 229940079593 drug Drugs 0.000 title claims abstract description 164
- 230000009849 deactivation Effects 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000001802 infusion Methods 0.000 title claims description 63
- 238000004590 computer program Methods 0.000 title claims description 9
- 238000002347 injection Methods 0.000 claims abstract description 207
- 239000007924 injection Substances 0.000 claims abstract description 207
- 239000007788 liquid Substances 0.000 claims abstract description 115
- 230000004044 response Effects 0.000 claims abstract description 21
- 238000001514 detection method Methods 0.000 claims abstract description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 147
- 229940125396 insulin Drugs 0.000 claims description 74
- 102000004877 Insulin Human genes 0.000 claims description 73
- 108090001061 Insulin Proteins 0.000 claims description 73
- 239000000243 solution Substances 0.000 claims description 54
- 238000004891 communication Methods 0.000 claims description 48
- 238000004364 calculation method Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 239000000126 substance Substances 0.000 description 27
- 230000002159 abnormal effect Effects 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000005259 measurement Methods 0.000 description 6
- 238000012937 correction Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000001610 euglycemic effect Effects 0.000 description 2
- 239000008155 medical solution Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940029980 drug used in diabetes Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940124535 smoking cessation aid Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M2005/16863—Occlusion detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/27—General characteristics of the apparatus preventing use
- A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims (7)
- 薬液注入量計算機の非活性化の時間を決定する方法であって、
薬液注入装置の注入エラーを検知するステップと、
前記注入エラーが検知されたことに応答して、薬液注入量計算機の非活性化の時間を決定するステップと
を含む、方法。 - 前記検知するステップは、
前記薬液注入装置の注入口詰まり(occlusion)が発生したことに応答して、前記注入エラーを検知するステップ
を含む、請求項1に記載の方法。 - 前記決定するステップは、
インスリン注入開始時間及びインスリン注入終了時間に基づいて、インスリン注入基準時間を計算するステップと、
現在時刻、予め設定されたインスリン持続時間、及び前記インスリン注入基準時間に基づいて前記非活性化の時間を決定するステップと
を含む、請求項2に記載の方法。 - 前記検知するステップは、
前記薬液注入装置との通信エラーが発生したことに応答して、前記注入エラーを検知するステップ
を含む、請求項1に記載の方法。 - 前記決定するステップは、
前記通信エラーが発生した通信エラー発生時間を取得するステップと、
現在時刻、予め設定されたインスリン持続時間、及び前記通信エラー発生時間に基づいて前記非活性化の時間を決定するステップと
を含む、請求項4に記載の方法。 - 薬液注入量計算機の非活性化の時間を決定する装置であって、
少なくとも1つのプログラムが保存されたメモリと、
前記少なくとも1つのプログラムを実行することによって演算を行うプロセッサと
を含み、
前記プロセッサは、
薬液注入装置の注入エラーを検知し、前記注入エラーが検知されたことに応答して薬液注入量計算機の非活性化の時間を決定するものである、
装置。 - 薬液注入装置の注入エラーを検知するステップと、
前記注入エラーが検知されたことに応答して、薬液注入量計算機の非活性化の時間を決定するステップと
を行うようにするプログラムが保存された1つ又は複数のコンピュータで読み取り可能な記録媒体を含むコンピュータプログラム製品。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0101685 | 2020-08-13 | ||
KR1020200101685A KR102464832B1 (ko) | 2020-08-13 | 2020-08-13 | 약물 주입량 계산기의 비활성화 시간을 결정하는 방법, 장치 및 컴퓨터 프로그램 제품 |
PCT/KR2021/008629 WO2022035057A1 (ko) | 2020-08-13 | 2021-07-07 | 약물 주입량 계산기의 비활성화 시간을 결정하는 방법, 장치 및 컴퓨터 프로그램 제품 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023538332A true JP2023538332A (ja) | 2023-09-07 |
JP7549404B2 JP7549404B2 (ja) | 2024-09-11 |
Family
ID=80247103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023510404A Active JP7549404B2 (ja) | 2020-08-13 | 2021-07-07 | 薬液注入量計算機の非活性化の時間を決定する方法、装置、及びコンピュータプログラム製品 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230187048A1 (ja) |
EP (1) | EP4183434A4 (ja) |
JP (1) | JP7549404B2 (ja) |
KR (2) | KR102464832B1 (ja) |
CN (1) | CN116033933A (ja) |
WO (1) | WO2022035057A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024090971A1 (ko) * | 2022-10-25 | 2024-05-02 | 주식회사 케어메디 | 약물 주입 장치 및 방법 |
WO2024117890A1 (ko) * | 2022-11-30 | 2024-06-06 | 이오플로우㈜ | 약액 주입 장치의 약액 주입 결과를 표시하는 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006034323A (ja) * | 2004-07-22 | 2006-02-09 | Woo Young Medical Co Ltd | 薬液定量自動注入装置及びその注入制御方法 |
ES2670420T3 (es) * | 2006-07-07 | 2018-05-30 | F. Hoffmann-La Roche Ag | Dispositivo de administración de fluidos y métodos de funcionamiento del mismo |
US8377031B2 (en) * | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
EP2093685A1 (en) * | 2008-02-21 | 2009-08-26 | F.Hoffmann-La Roche Ag | Drug administration device having a bolus administration profile controller |
EP2335755A1 (en) | 2009-12-17 | 2011-06-22 | Sanofi-Aventis Deutschland GmbH | Device and method for delivery of two or more drug agents |
AU2015308144B2 (en) * | 2014-08-26 | 2020-07-02 | Debiotech S.A. | Detection of an infusion anomaly |
KR101994815B1 (ko) * | 2017-06-28 | 2019-10-01 | 건국대학교 글로컬산학협력단 | 약물 주입 장치 및 그의 상태 판단 방법 |
KR102134627B1 (ko) * | 2019-08-06 | 2020-07-17 | ㈜신명메디에스 | 휴대용 인슐린 주입기 및 그 휴대용 인슐린 주입기의 비정상 작동 알람 방법 |
-
2020
- 2020-08-13 KR KR1020200101685A patent/KR102464832B1/ko active IP Right Grant
-
2021
- 2021-07-07 WO PCT/KR2021/008629 patent/WO2022035057A1/ko unknown
- 2021-07-07 EP EP21856064.7A patent/EP4183434A4/en active Pending
- 2021-07-07 JP JP2023510404A patent/JP7549404B2/ja active Active
- 2021-07-07 CN CN202180056157.4A patent/CN116033933A/zh active Pending
-
2022
- 2022-11-03 KR KR1020220145220A patent/KR20220152985A/ko not_active Application Discontinuation
-
2023
- 2023-02-08 US US18/107,074 patent/US20230187048A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022035057A1 (ko) | 2022-02-17 |
JP7549404B2 (ja) | 2024-09-11 |
EP4183434A1 (en) | 2023-05-24 |
EP4183434A4 (en) | 2023-12-20 |
KR20220152985A (ko) | 2022-11-17 |
US20230187048A1 (en) | 2023-06-15 |
KR102464832B1 (ko) | 2022-11-09 |
CN116033933A (zh) | 2023-04-28 |
KR20220021179A (ko) | 2022-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022126862A (ja) | 流体送達のためのシステムおよび方法 | |
US20230187048A1 (en) | Method, device, and computer program product for determining inactive time of drug infusion calculator | |
JP2008531159A (ja) | 薬剤送達流量を変更する装置 | |
US20160158471A1 (en) | Integration of glucose data to adjust inhaled insulin dose | |
KR20230127950A (ko) | 최적의 인슐린 주입량을 산출하는 방법, 장치 및 컴퓨터 프로그램 제품 | |
KR102419031B1 (ko) | 약물 주입 장치의 사용 기간에 따른 알림을 제공하는 방법, 장치 및 컴퓨터 프로그램 제품 | |
US20230211081A1 (en) | Liquid medicine injection device, drug injection device, and method for determining remaining amount of drug thereof | |
KR102482395B1 (ko) | 약물 주입 장치 및 그의 약물 잔량을 결정하는 방법 | |
EP4254422A1 (en) | Automatic drug delivery system having multiple communication options | |
JP2023540356A (ja) | 薬液注入装置 | |
KR20240116500A (ko) | 약물 전달을 위한 임베디드 제제 최적화 | |
KR20240063471A (ko) | 약액 주입 장치에서 약액 주입량 결정 방법 | |
EP4380649A1 (en) | Systems and methods for processing continuous glucose monitor values in automated insulin delivery | |
CN118632718A (zh) | 带有双储存器的正排量泵送机构 | |
CN118119417A (zh) | 用于正排量泵的驱动机构 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230210 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240424 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240806 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240823 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7549404 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |